Original language | English |
---|---|
Pages (from-to) | 39-39 |
Journal | ONCOLOGY RESEARCH AND TREATMENT |
Volume | 39 |
Publication status | Published - Oct 2016 |
Deregulated CD62L expression predicts molecular response to nilotinib therapy in early chronic phase Chronic Myelogenous Leukemia (CML-CP)
D. Wolf, S. Mustjoki, B. -T Gjertsen, G. Gastl, M. Baldauf, Z. Trajanoski, F. Giles, A. Hochhaus, T. Ernst, T. Schenk, J. Janssen, K. Porkka, S. Sopper
Research output: Contribution to journal › Article › Academic › peer-review